Annual CFO
-$393.28 M
-$192.00 M-95.39%
December 31, 2023
Summary
- As of February 12, 2025, LEGN annual cash flow from operations is -$393.28 million, with the most recent change of -$192.00 million (-95.39%) on December 31, 2023.
- During the last 3 years, LEGN annual CFO has fallen by -$170.27 million (-76.35%).
- LEGN annual CFO is now -227.82% below its all-time high of $307.68 million, reached on December 31, 2018.
Performance
LEGN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$75.82 M
-$74.17 M-4492.49%
September 30, 2024
Summary
- As of February 12, 2025, LEGN quarterly cash flow from operations is -$75.82 million, with the most recent change of -$74.17 million (-4492.49%) on September 30, 2024.
- Over the past year, LEGN quarterly CFO has increased by +$19.82 million (+20.73%).
- LEGN quarterly CFO is now -480.12% below its all-time high of $19.95 million, reached on September 30, 2019.
Performance
LEGN Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$157.60 M
-$14.97 M-10.50%
September 30, 2024
Summary
- As of February 12, 2025, LEGN TTM cash flow from operations is -$157.60 million, with the most recent change of -$14.97 million (-10.50%) on September 30, 2024.
- Over the past year, LEGN TTM CFO has increased by +$235.68 million (+59.93%).
- LEGN TTM CFO is now -3600.40% below its all-time high of -$4.26 million, reached on March 31, 2019.
Performance
LEGN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
LEGN Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -95.4% | +20.7% | +59.9% |
| 3 y3 years | -76.3% | +20.7% | +59.9% |
| 5 y5 years | -227.8% | +20.7% | +59.9% |
LEGN Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -98.2% | at low | -588.6% | +45.5% | -10.5% | +59.9% |
| 5 y | 5-year | -373.5% | at low | -588.6% | +45.5% | -89.7% | +59.9% |
| alltime | all time | -227.8% | at low | -480.1% | +45.5% | -3600.4% | +59.9% |
Legend Biotech Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$75.82 M(+4492.5%) | -$157.60 M(+10.5%) |
| Jun 2024 | - | -$1.65 M(-110.6%) | -$142.63 M(-40.2%) |
| Mar 2024 | - | $15.52 M(-116.2%) | -$238.54 M(-39.3%) |
| Dec 2023 | -$393.28 M(+95.4%) | -$95.64 M(+57.2%) | -$393.28 M(+13.2%) |
| Sep 2023 | - | -$60.85 M(-37.6%) | -$347.37 M(-3.1%) |
| Jun 2023 | - | -$97.57 M(-29.9%) | -$358.64 M(+37.0%) |
| Mar 2023 | - | -$139.22 M(+179.9%) | -$261.81 M(+30.1%) |
| Dec 2022 | -$201.28 M(+1.4%) | -$49.74 M(-31.0%) | -$201.28 M(-9.0%) |
| Sep 2022 | - | -$72.11 M(+9644.9%) | -$221.09 M(+14.2%) |
| Jun 2022 | - | -$740.00 K(-99.1%) | -$193.57 M(-22.7%) |
| Mar 2022 | - | -$78.69 M(+13.1%) | -$250.37 M(+26.2%) |
| Dec 2021 | -$198.47 M | -$69.55 M(+56.0%) | -$198.47 M(+7.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$44.59 M(-22.5%) | -$184.87 M(-9.7%) |
| Jun 2021 | - | -$57.54 M(+114.8%) | -$204.65 M(+0.3%) |
| Mar 2021 | - | -$26.79 M(-52.1%) | -$204.00 M(-8.5%) |
| Dec 2020 | -$223.00 M(+168.5%) | -$55.95 M(-13.1%) | -$223.00 M(-1.8%) |
| Sep 2020 | - | -$64.37 M(+13.2%) | -$227.04 M(+59.1%) |
| Jun 2020 | - | -$56.88 M(+24.2%) | -$142.72 M(+14.5%) |
| Mar 2020 | - | -$45.80 M(-23.7%) | -$124.60 M(+50.0%) |
| Dec 2019 | -$83.06 M(-127.0%) | -$59.99 M(-400.7%) | -$83.06 M(+259.9%) |
| Sep 2019 | - | $19.95 M(-151.5%) | -$23.08 M(-46.4%) |
| Jun 2019 | - | -$38.77 M(+810.2%) | -$43.02 M(+910.2%) |
| Mar 2019 | - | -$4.26 M | -$4.26 M |
| Dec 2018 | $307.68 M | - | - |
FAQ
- What is Legend Biotech annual cash flow from operations?
- What is the all time high annual CFO for Legend Biotech?
- What is Legend Biotech annual CFO year-on-year change?
- What is Legend Biotech quarterly cash flow from operations?
- What is the all time high quarterly CFO for Legend Biotech?
- What is Legend Biotech quarterly CFO year-on-year change?
- What is Legend Biotech TTM cash flow from operations?
- What is the all time high TTM CFO for Legend Biotech?
- What is Legend Biotech TTM CFO year-on-year change?
What is Legend Biotech annual cash flow from operations?
The current annual CFO of LEGN is -$393.28 M
What is the all time high annual CFO for Legend Biotech?
Legend Biotech all-time high annual cash flow from operations is $307.68 M
What is Legend Biotech annual CFO year-on-year change?
Over the past year, LEGN annual cash flow from operations has changed by -$192.00 M (-95.39%)
What is Legend Biotech quarterly cash flow from operations?
The current quarterly CFO of LEGN is -$75.82 M
What is the all time high quarterly CFO for Legend Biotech?
Legend Biotech all-time high quarterly cash flow from operations is $19.95 M
What is Legend Biotech quarterly CFO year-on-year change?
Over the past year, LEGN quarterly cash flow from operations has changed by +$19.82 M (+20.73%)
What is Legend Biotech TTM cash flow from operations?
The current TTM CFO of LEGN is -$157.60 M
What is the all time high TTM CFO for Legend Biotech?
Legend Biotech all-time high TTM cash flow from operations is -$4.26 M
What is Legend Biotech TTM CFO year-on-year change?
Over the past year, LEGN TTM cash flow from operations has changed by +$235.68 M (+59.93%)